FDA label 124b7379-b6b5-4b2b-8df2-06373ba8dd7f

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
b8eb74cf-9451-4305-a14a-3d0fc0b0c10d
SPL ID
124b7379-b6b5-4b2b-8df2-06373ba8dd7f
Version
4
Effective date
2021-02-15
Source export date
2026-10-12
Source partition
13
Source file
https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/b8dac220ac9fc8ffb4d86c6e00ece30169fc4575ca0cc92e5c9ce1a524fb0249/drug-label-0013-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 03:09:12

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings • For external use only. • According to homeopathic principles, symptoms may temporarily worsen before improving (Initial exacerbation of symptoms). • Replace cap tightly after every use. • To avoid contamination, do not touch the tip of the bottle to any surface. • To avoid contamination use within 30 days of opening. Expiration date only refers to unopened bottle. • Our drops will not harm contact lenses, however we recommend not wearing contacts while experiencing eye irritation. If pregnant, trying to get pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Do not use: • if the solution changes color or becomes cloudy Stop use and ask a doctor if: • symptoms worsen or persist for more than 72 hours • you experience eye pain or changes in vision

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.